We hypothesize that the increased prevalence of non-infectious co-morbidities (NICM) observed among HIV-infected pts may will result in increased direct financial costs of medical care in compared to general population. Our objective was to provide estimates of and describe factors contributing to direct costs for medical care among HIV-infected patients, with a focus on financial costs related to NICM management.
Cost of non-infectious co-morbidities in patients with HIV / Guaraldi, Giovanni; Zona, Stefano; Menozzi, Marianna; Carli, Federica; Bagni, P; Berti, A; Rossi, E; Orlando, Gabriella; Zoboli, G; Palella, F.. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 16:(2011), pp. A27-A27. (Intervento presentato al convegno 13th international workshop on Adverse Drug Reactions and Co-morbidities in HIV. tenutosi a Rome nel 14-16 Jul 2011).
Cost of non-infectious co-morbidities in patients with HIV
GUARALDI, Giovanni;ZONA, Stefano;Menozzi, Marianna;CARLI, FEDERICA;ORLANDO, Gabriella;
2011
Abstract
We hypothesize that the increased prevalence of non-infectious co-morbidities (NICM) observed among HIV-infected pts may will result in increased direct financial costs of medical care in compared to general population. Our objective was to provide estimates of and describe factors contributing to direct costs for medical care among HIV-infected patients, with a focus on financial costs related to NICM management.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
